News

VIEW ALL

FELDAN IS ATTENDING BIO INTERNATIONAL CONVENTION, JUNE 4-7 2018 IN BOSTON, USA.

Our CEO François-Thomas Michaud and Strategic development director Vincent Menard are pleased to be in Boston this week for the BIO...

June 4, 2018

Feldan Therapeutics awarded US Patent for the second generation of its Feldan Shuttle platform

QUEBEC CITYMay 29, 2018 -  Feldan Therapeutics, Inc. announced today the issuance of a new patent related to the refinement of the...

May 29, 2018

FELDAN AT TIDES 2018

Feldan Therapeutics’ Research Director, Dr. David Guay, will be attending TIDES: Oligonucleotides and Peptide Therapeutics Conference...

May 1, 2018

FELDAN THERAPEUTICS AT RESI 2018 (TORONTO)

Our CEO Francois-Thomas Michaud and Strategic Alliance Director, Vincent Ménard, MBA Ph.D. will be attending RESI2018 conference in...

April 9, 2018

READ THE LATEST ON FELDAN SHUTTLE TECHNOLOGY

Read the new article on the Feldan Shuttle Technology published in PLOS One  (April 2018) : ...

April 5, 2018

CQDM WILL PARTNER WITH FELDAN TO SUPPORT A $1.2M PROJECT

QUÉBEC city, March 29, 2018 – CQDM is pleased to announce the selection of a new Quantum Leap project jointly with Feldan...

March 29, 2018

FELDAN THERAPEUTICS WILL BE ATTENDING THE INNATE KILLER SUMMIT 2018

Feldan Therapeutics will be attending the Innate Killer Summit from March 27  to 29 in San Diego, CA, USA.

Come and meet with...

March 16, 2018

READ THE LATEST ON FELDAN SHUTTLE TECHNOLOGY

Read the new article on the Feldan Shuttle Technology published in Drug Development & Delivery edition on January 2018.
January 17, 2018

FELDAN THERAPEUTICS AND GREENCROSS LABCELL ANNOUNCE START OF JOINT COLLABORATION

 

January 15, 2018

Feldan Therapeutics new web site !

Feldan Therapeutics is proud to reveal its new website !

September 4, 2017